3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
149
Breast Neoplasms
87
Colorectal Neoplasms
64
Neoplasms
53
Pancreatic Neoplasms
52
Lung Neoplasms
49
Neoplasm Metastasis
45
Stomach Neoplasms
43
Ovarian Neoplasms
42
Rectal Neoplasms
41
Esophageal Squamous Cell Carcinoma
34
Esophageal Neoplasms
33
Squamous Cell Carcinoma of Head and Neck
30
Head and Neck Neoplasms
30
Leukemia, Myeloid, Acute
28
Recurrence
23
Triple Negative Breast Neoplasms
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Small Cell Lung Carcinoma
20
Nasopharyngeal Carcinoma
20
Glioblastoma
20
Uterine Cervical Neoplasms
19
Fallopian Tube Neoplasms
19
Lymphoma, Non-Hodgkin
18
Lymphoma
18
Colonic Neoplasms
17
Prostatic Neoplasms
16
Leukemia
15
Carcinoma, Ovarian Epithelial
15
Melanoma
14
Interventions
Temozolomide
11
Cyclophosphamide
11
Radiotherapy
7
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Cisplatin
6
Vincristine
5
Etoposide
5
Carboplatin
5
antineoplaston AS 2-1
4
antineoplaston A10
4
sargramostim
3
Thiotepa
3
Melphalan
3
Carmustine
3
Automobiles
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
gallium Ga 68 dotatate
2
fludarabine
2
dactolisib
2
aldesleukin
2
Thalidomide
2
TH 302
2
Paclitaxel
2
Irinotecan
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Gadolinium DTPA
2
Everolimus
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuroectodermal Tumors, Primitive
×
Drug Therapy
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled